Developing a porcine transplantation model: Efficient gene transfer into porcine vascular cells

Transplantation

Volumn 77, Issue 9 SUPPL., 2004, Pages 1443-1451

  Chen, Daxin ^a   Morgan, Finn ^a   Berton, Ivan ^a   Herbert, Paul E ^a   Lechler, Robert I ^a   Dorling, Anthony ^a   Williams, Gordon ^a   Warrens, Anthony N ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; LACTATE DEHYDROGENASE; LIPOSOME;

ANIMAL CELL; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; CYTOTOXICITY; DNA DEGRADATION; DNA VECTOR; ENDOTHELIUM CELL; ENZYME RELEASE; GENE TRANSFER; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SOUTHERN BLOTTING; SWINE; VASCULAR SMOOTH MUSCLE; XENOTRANSPLANTATION;

ANIMALS; AORTA; CAROTID ARTERIES; CELLS, CULTURED; ENDOTHELIAL CELLS; FLUORESCENT DYES; GENE TRANSFER TECHNIQUES; INDOLES; SWINE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 2442676465     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000120951.33082.64     Document Type: Article

References (22)

1. Nishikawa M, Huang L. Nonviral vectors in the new millennium: Delivery barriers in gene transfer. Hum Gene Ther 2001; 12(8): 861.
2. Nguyen T, Nery J, Joseph S, et al. Mouse adenovirus (MAV-1) expression in primary human endothelial cells and generation of a full-length infectious plasmid. Gene Ther 1999; 6(7): 1291.
3. Reynolds P, Zinn K, Gavrilyuk V, et al. A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. Mol Ther 2000; 2(6): 572.
4. Takei Y, Maruyama A, Kawano S, et al. Targeted gene transfer to sinusoidal endothelial cells and expression in vivo. Transplant Proc 31 (1-2):790, 1999.
5. Reynolds PN, Nicklin SA, Kaliberova L, et al. Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo. Nat Biotechnol 2001; 19(9): 838.
6. Dorling A, Riesbeck K, Warrens A, et al. Clinical xenotransplantation of solid organs. Lancet 1997; 349: 867.
7. Sepp A, Skacel P, Lindstedt R, et al. Expression of alpha- 1,3-galactose and other type 2 oligosaccharide structures in a porcine endothelial cell line transfected with human alpha-1,2-fucosyltransferase cDNA. J Biol Chem 1997; 272(37): 23104.
8. Sandrin M, Fodor W, Mouhtouris E, et al. Enzymatic remodelling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995; 1: 1261.
9. Tanemura M, Miyagawa S, Koyota S, et al. Reduction of the major swine xenoantigen, the alpha-galactosyl epitope by transfection of the alpha2,3-sialyltransferase gene. J Biol Chem 1998; 273(26): 16421.
10. Seebach J, Comrack C, Germana S, et al. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. J Immunol 1997; 159(7): 3655.
11. Chen D, Riesbeck K, McVey J, et al. Regulated inhibition of coagulation by porcine endothelial cells expressing P-selectin-tagged hirudin and tissue factor pathway inhibitor fusion proteins. Transplantation 1999; 68(6): 832.
12. Albert F, Eckdahl T, Fitzgerald D, et al. Heterogeneity in the actions of drugs that bind in the DNA minor groove. Biochemistry 1999; 38: 10135.
13. Forrow S, Lee M, Souhami R, et al. The effect of AT and GC sequence specific minor groove-binding agents on restriction endonuclease activity. Chem Biol Interact 1995; 96(2): 125.
14. Jeppesen C, Nielsen P. Photofootprinting of drug-binding sites on DNA using diazo- and azido-9-aminoacridine derivatives. Eur J Biochem 1989; 182: 437.
15. Loyter A, Scangos G, Ruddle FH. Mechanisms of DNA uptake by mammalian cells: Fate of exogenously added DNA monitored by the use of fluorescent dyes. Proc Natl Acad Sci USA 1982; 79(2): 422.
16. Cotten M, Baker A, Saltik M, et al. Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus. Gene Ther 1994; 1(4): 239.
17. Riesbeck K, Chen D, Kemball-Cook G, et al. Expression of hirudin fusion proteins in mammalian cells: A strategy for prevention of intravascular thrombosis. Circulation 1998; 98: 2744.
18. Barrett LA, Mergner WJ, Trump BF. Long-term culture of human aortas: Development of atherosclerotic-like plaques in serum-supplemented medium. In Vitro 1979; 15(12): 957.
19. Lewis J, Lin K, Kothavale A, et al. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc Natl Acad Sci USA 1996; 93: 3176.
20. Storl K, Storl J, Zimmer C, et al. Minor-groove binders are inhibitors of the catalytic activity of DNA gyrases. FEBS Lett 1993; 317(1-2): 157.
21. Palu G, Valisena S, Barcellona ML, et al. DAPI-pUC8 complex: A tool to investigate biological effects of nucleic acid-drug interaction. Biochem Biophys Res Commun 1987; 145(1): 40.
22. Parolin C, Zanotti G, Palu G. A model for the sequence-dependent DNA binding of 4′,6-diamidino-2-phenylindole (DAPI). Biochem Biophys Res Commun 1995; 208(1): 332.